Enanta aims to raise $50M as it advances RSV therapy; Hinge, Kyorin make a deal

Plus, news about Palisade Bio, Betta Pharmaceuticals, Binhui Biopharmaceutical, Appili Therapeutics, Vitalex Biosciences, Alpha Cognition, Klotho Neurosciences and Turn Biotechnologies: 💰 Enanta seeks $50M public offering: The raise comes days after ...